Materials & Resources » Chemicals | Clariant AG

Clariant AG | Income Statement

Fiscal year is January-December. All values CHF Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
6,076
6,116
5,807
5,847
6,377
6,623
Cost of Goods Sold (COGS) incl. D&A
4,332
4,344
4,020
4,049
4,465
4,679
Gross Income
1,744
1,772
1,787
1,798
1,912
1,944
SG&A Expense
1,233
1,262
1,268
1,264
1,335
1,435
EBIT
511
510
519
534
569
509
Unusual Expense
123
228
115
107
176
93
Non Operating Income/Expense
22
171
100
85
7
11
Interest Expense
139
160
92
98
78
82
Pretax Income
282
304
223
253
334
335
Income Tax
22
144
73
75
135
109
Equity in Affiliates
63
75
77
85
103
130
Consolidated Net Income
323
235
227
263
302
356
Net Income
306
175
217
253
277
337
Net Income After Extraordinaries
632
198
205
253
277
337
Net Income Available to Common
267
172
231
253
277
337
EPS (Basic)
0.06
0.48
0.71
0.78
0.84
1.02
Basic Shares Outstanding
313
320
322
324
328
330
EPS (Diluted)
0.06
0.47
0.71
0.78
0.84
1.02
Diluted Shares Outstanding
314
322
324
325
330
330
EBITDA
795
792
776
799
870
834
Other Operating Expense
-
-
-
-
8
-
Non-Operating Interest Income
11
11
11
9
12
12
Minority Interest Expense
17
60
10
10
25
19

About Clariant

View Profile
Address
Rothausstrasse 61
Muttenz Basel-Landschaft (Basle Country) 4132
Switzerland
Employees -
Website http://www.clariant.com
Updated 07/08/2019
Clariant AG engages in the development, manufacture, distribution, and sale of specialty chemicals. It operates through the following segments: Care Chemicals, Catalysis, Natural Resources, and Plastics & Coatings. The Care Chemicals segment comprises the industrial & consumer specialties business unit (BU), food additives as well as the future industrial biotechnology business.